Accelerating Hope: Clinical Trials for Hard-to-Treat Cancers Award supports researchers conducting clinical trials for hard-to-treat childhood cancers to advance safer, less toxic therapies.
Support for innovative research to improve cancer control through behavior modification, screening, and understanding etiologic factors, with the aim of advancing population-based cancer studies.
Funding opportunity for advancing nanotechnology-based cancer treatments to improve effectiveness through innovative nanoparticle designs and cargos.
The National Cancer Institute will fund hypothesis-driven research in cancer epidemiology cohort studies to address gaps in cancer causes and survivorship, supporting cohort maintenance and data sharing.
This grant funds research on causes, biological mechanisms, and early detection of non-hereditary early-onset cancers (ages 18-49) to inform prevention and control strategies.